These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 8765420

  • 21. gp130-stimulating designer cytokine Hyper-interleukin-6 synergizes with murine stroma for long-term survival of primitive human hematopoietic progenitor cells.
    Götze KS, Keller U, Rose-John S, Peschel C.
    Exp Hematol; 2001 Jul; 29(7):822-32. PubMed ID: 11438204
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Role of Soluble Interleukin-6 Receptor With Interleukin-6 in Human Hematopoiesis.
    Tsuji K, Nakahata T.
    Hematology; 1997 Jul; 2(2):143-9. PubMed ID: 27406805
    [Abstract] [Full Text] [Related]

  • 25. Interleukin-6 receptor-interleukin-6 fusion proteins with enhanced interleukin-6 type pleiotropic activities.
    Chebath J, Fischer D, Kumar A, Oh JW, Kolett O, Lapidot T, Fischer M, Rose-John S, Nagler A, Slavin S, Revel M.
    Eur Cytokine Netw; 1997 Dec; 8(4):359-65. PubMed ID: 9459615
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Interleukin 6 receptor expression by human cord blood- or peripheral blood-derived primitive haematopoietic progenitors implies acquisition of different functional properties.
    Minamiguchi H, Yahata N, Kimura T, Fujiki H, Harada S, Wang J, Okuda K, Kaneko H, Hodohara K, Banba T, Yasukawa K, Ohyashiki JH, Ohyashiki K, Abe T, Sonoda Y.
    Br J Haematol; 2000 Aug; 110(2):327-38. PubMed ID: 10971389
    [Abstract] [Full Text] [Related]

  • 30. Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses.
    Jostock T, Müllberg J, Ozbek S, Atreya R, Blinn G, Voltz N, Fischer M, Neurath MF, Rose-John S.
    Eur J Biochem; 2001 Jan; 268(1):160-7. PubMed ID: 11121117
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. The soluble interleukin-6 receptor is a mediator of hematopoietic and skeletal actions of parathyroid hormone.
    Cho SW, Pirih FQ, Koh AJ, Michalski M, Eber MR, Ritchie K, Sinder B, Oh S, Al-Dujaili SA, Lee J, Kozloff K, Danciu T, Wronski TJ, McCauley LK.
    J Biol Chem; 2013 Mar 08; 288(10):6814-25. PubMed ID: 23297399
    [Abstract] [Full Text] [Related]

  • 33. Stem cell factor as a survival and growth factor in human normal and malignant hematopoiesis.
    Hassan HT, Zander A.
    Acta Haematol; 1996 Mar 08; 95(3-4):257-62. PubMed ID: 8677752
    [Abstract] [Full Text] [Related]

  • 34. Neutralization of autocrine transforming growth factor-beta in human cord blood CD34(+)CD38(-)Lin(-) cells promotes stem-cell-factor-mediated erythropoietin-independent early erythroid progenitor development and reduces terminal differentiation.
    Akel S, Petrow-Sadowski C, Laughlin MJ, Ruscetti FW.
    Stem Cells; 2003 Mar 08; 21(5):557-67. PubMed ID: 12968110
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Combination of interleukin-6 and soluble interleukin-6 receptors induces differentiation and activation of JAK-STAT and MAP kinase pathways in MG-63 human osteoblastic cells.
    Nishimura R, Moriyama K, Yasukawa K, Mundy GR, Yoneda T.
    J Bone Miner Res; 1998 May 08; 13(5):777-85. PubMed ID: 9610741
    [Abstract] [Full Text] [Related]

  • 38. The role of transsignalling via the agonistic soluble IL-6 receptor in human diseases.
    Kallen KJ.
    Biochim Biophys Acta; 2002 Nov 11; 1592(3):323-43. PubMed ID: 12421676
    [Abstract] [Full Text] [Related]

  • 39. Resistance to interleukin 6 in human non-small cell lung carcinoma cell lines: role of receptor components.
    Ganapathi MK, Weizer AK, Borsellino S, Bukowski RM, Ganapathi R, Rice T, Casey G, Kawamura K.
    Cell Growth Differ; 1996 Jul 11; 7(7):923-9. PubMed ID: 8809410
    [Abstract] [Full Text] [Related]

  • 40. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
    Gehling UM, Ryder JW, Hogan CJ, Hami L, McNiece I, Franklin W, Williams S, Helm K, King J, Shpall EJ.
    Exp Hematol; 1997 Oct 11; 25(11):1125-39. PubMed ID: 9328449
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.